Mohamed Shanshal

Profile Picture of Mohamed Shanshal
Title
Senior associated consultant
Department
Medical Oncology
Institution
Mayo Clinic

Education

  • MD

Research Interests

Phase 1 Drug Development   T Cell Engagers   Targeted Therapy in Thoracic Malignancies  

  View all research interests

Biography

I am a medical oncologist with a strong commitment to advancing cancer care and research. My journey began with a comprehensive medical education in Baghdad, Iraq, and further training in Internal Medicine and Hematology/Oncology in the United States. I have had the privilege of working at esteemed institutions, including Mayo Clinic and also in rural areas of Kentucky, where I provided compassionate care to cancer patients. My expertise lies in evaluating and designing early-phase clinical trials for novel therapeutic agents, incorporating biomarkers, and understanding regulatory processes for new treatments. With multiple certifications, awards, and a dedication to excellence, I am determined to make a significant impact on the field of Oncology, decrease disparities in cancer care and continue to contribute to the improvement of cancer treatment and patient outcomes.

Homepages

Contact Information

  200 First street SW, Rochester, MN 55902

Research
Not mentioned yet. (?)
List of Publications (22)
In 2023
22

Shanshal, M., et al., T-Cell Engagers in Solid Cancers—Current Landscape and Future Directions. Cancers, 2023. 15(10): p. 2824.

Found on CV
21

Mohamed Shanshal, Wen wee Ma, MBBS et al; Safety data of Phase I Trial of Sonidegib and Pembrolizumab in Non-Small Cell Lung Cancer. ASCO 2023 Abstract

Found on CV
20

First-in-human phase 1 trial of the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of WSD0922-Fu: Initial report from dose escalation cohort. Sani H. Kizilbash, Kurt Jaeckle, Maciej Mrugala, Jacob Allred, Joel Reid, Anita Lammers, Wei Zhong, Konstantinos Leventakos, Aaron Mansfield, Mohamed Shanshal, Wen Wee Ma, Joon Uhm, Jian L. Campian, Michael Ruff, Ugur Sener, Evanthia Galanis, Terence Burns, Caterina Giannini, Jann Sarkaria, Alex A. Adjei. ASCO 2023 Abstract

Found on CV
In 2020
19

Phuong Ngo, Mohamed Shanshal, Adam Rojan. Immunotherapy in pancreatic cancer and the importance of tumour testing. BMJ Case Rep. 2020; 13(7): e235774.

Found on CV
In 2017
18

Retrospective study: Effectiveness of colonoscopy for patients 75 years of age and older, Mohamed Shanshal, Shah Pallavi, ASCO Abstract; 2017.

Found on CV
17

Karam, D., Mohamed Shanshal, et al., Impact of colonoscopy on patients older than 75. Journal of Clinical Oncology, 2017. 35(15_suppl): p. e15096-e15096.

Found on CV
16

Quality improvement study; G-CSF Use in Febrile Neutropenia, UMC hospital, Lubbock, Texas 06/2017.

Found on CV
15

Khalil S, Yendala R, D'Cunha N, Hardwicke F, Shanshal M. Giant-cell tumor of bone with pathological evidence of blood vessel invasion. Hematol Oncol Stem Cell Ther. 2017 Sep;10(3):161-163. doi: 10.1016/j.hemonc.2017.05.031. Epub 2017 Jun. PubMed PMID: 28633039.

Found on CV
14

Shanshal, M., et al., Effect of amplification of xenobiotic detoxification pathways genes on survival in lung adenocarcinoma versus squamous cell carcinoma bases on the Cancer Genome Atlas provisional database. Journal of Clinical Oncology, 2017. 35(15_suppl): p. e14093-e14093.

Found on CV
In 2016
13

Dasatinib Induced T-Cell Mediated Colitis, Case Report and Review of the Literature. Shanshal Ma, Shakespeare Ab, Thirumala Sc, Fenton Bd, Quick De. Acta Haematol 2016; 136:219-228.

Found on CV
12

Shanshal M, Awasthi S. MINI01.05: RALPB1 Mediate ALK Resistance in Non-Small Cell Lung Cancer: Topic: Medical Oncology. J Thorac Oncol. 2016 Nov;11(11S): S258-S259. doi: 10.1016/j.jtho.2016.09.020. PubMed PMID: 27969453.

Found on CV
In 2015
11

Upper esophageal adenocarcinoma, review of cases; Radhi, Saba, Payne, Drew, Mohamed shanshal 2015.

Found on CV
10

Novel biomarkers for non small cell lung cancer (NSCLC); Lukman Tijani, Cynthia Jumper, Leonardo Mirandola, Mohamed Shanshal, Hassan Kaleem, Maurizio Chiriva-Internati. Texas Tech Health Ccience Center, Lubbock, TX/USA. 09/2015.

Found on CV
9

Anita Sultan1 MD, Henry Igid1MD, Alan Haynes2 MD, Mohamad Shanshal1 MD, Lukman Tijani1 MD Department of Internal Medicine1 and Urology2, Texas Tech University Health Sciences Center, Lubbock, Texas Liposarcoma of the spermatic cord-rarest entity of a rare tumor. Southern society of clinical investigators 2015

Found on CV
In 2014
8

Case report, accepted at the ACP; Papillary adenocarcinoma of rete testis, Mohammed Shanshal MD, Vallikantha Nellaiappan MD, Ridha Ali MD, Rami Haddad MD 2014.

Found on CV
7

Case report at the ACP (american college of physician): The Mycobacterial Fifty Shades of Grey, How to Approach Mycobacterial Avium Complex in Asymptomatic Immunocompetent, Ridha Ali MD, Mohamed Shanshal 2014.

Found on CV
In 2013
6

A Case Report Metastatic Hepatocellular Carcinoma on Single Agent Sorafenib: Mohamed Shanshal, Rami Haddad. Journal of GHR 2013 May 21 2(5): 610-612

Found on CV
In 2012
5

Review article; Chronic Lymphocytic Leukemia, Mohammed Shanshal, MD, and Rami Y. Haddad, MD, FACP. Disease a month 04/2012

Found on CV
Unspecified
4

AHA; Correction Of Anemia And Quality Of Life In Patients Congestive Heart Failure: A Meta-analysis. Singh M, Alkhafazi N, Shanshal M, Parmar S, Khosla S, Arora R. Abstract No. 14878

Found on CV
3

A. Sultan1 MD, C. Ibilibor2 MD, M. Suarez1 MD, M. Shanshal1 MD, F. Hardwicke1MD, Department of Internal Medicine1, Department of Urology2, Texas Tech University Health Sciences Center, Lubbock, TX. Small cell cancer-with rare presentation as bladder cancer. Southern society of clinical investigators.

Found on CV
2

Shanshal, Mohamed, Jin Zhao, Thiels, Cornelius. Book Chapter; Treatment of peritoneal mesothelioma. Submitted for publications.

Found on CV
1

Use of MTAP inhibitors in treatment of solid cancers with MTAP mutation. In collaboration with Dr. Leventakos.

Found on CV
Search Profiles
Colleagues
Recommended Grants